Nutriband (NTRB) said Friday that it received a patent in Macao for its abuse and misuse deterrent transdermal systems, which covers the company's Aversa abuse deterrent transdermal technology.
The company said the Macao Intellectual Property Office granted the patent on Feb. 11, adding to patents in 46 other countries for its abuse deterrent transdermal technology.
Nutriband said it is working with Kindeva Drug Delivery to develop Aversa Fentanyl, which integrates the Aversa abuse deterrent transdermal technology into Kindeva's transdermal fentanyl patch system.
免責聲明：投資有風險，本文並非投資建議，以上內容不應被視為任何金融產品的購買或出售要約、建議或邀請，作者或其他用戶的任何相關討論、評論或帖子也不應被視為此類內容。本文僅供一般參考，不考慮您的個人投資目標、財務狀況或需求。TTM對信息的準確性和完整性不承擔任何責任或保證，投資者應自行研究並在投資前尋求專業建議。